ARCHIVES

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

This article is from The Cancer Letter archive.

Vol. 18 No. 27 | July 3, 1992

Download PDF Visit The Full Archive

Related Articles

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999

In Brief: Daniel Nixon Of Emory to Head Prevention Program; Henderson To Get Rosenthal Award

January 30, 1987